CME GROUP INC (CME) Stock Analyst Earnings Estimates
NASDAQ:CME - Nasdaq - US12572Q1058 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.218B 44.45% | 10.854B 50.38% | 10.209B -5.94% | 6.574B -35.61% | 6.843B 4.09% | 7.211B 5.38% | 7.273B 0.86% | 7.632B 4.94% | |
| EBITDA YoY % growth | 5.577B 67.10% | 9.064B 62.52% | 8.347B -7.90% | 4.67B -44.05% | 4.943B 5.85% | 5.339B 8.01% | 5.485B 2.73% | 5.831B 6.31% | |
| EBIT YoY % growth | 5.214B 76.63% | 8.711B 67.06% | 8.011B -8.04% | 4.589B -42.71% | 4.788B 4.34% | 5.113B 6.79% | 5.369B 5.01% | 5.713B 6.41% | |
| Operating Margin | 72.24% | 80.25% | 78.46% | 69.81% | 69.97% | 70.91% | 73.82% | 74.86% | |
| EPS YoY % growth | 7.98 19.28% | 9.34 17.04% | 10.26 9.85% | 11.27 9.80% | 11.74 4.22% | 12.65 7.73% | 13.43 6.21% | 14.44 7.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.73 1.78% | 2.72 7.88% | 2.92 4.12% | 2.80 -5.24% | 2.85 4.58% | 2.76 1.45% |
| Revenue Q2Q % growth | 1.576B -0.53% | 1.62B 6.21% | 1.71B 4.12% | 1.672B -1.18% | 1.702B 7.99% | 1.684B 3.95% |
| EBITDA Q2Q % growth | 1.091B -52.66% | 1.082B -51.27% | 1.221B -41.39% | 1.187B -57.81% | 1.22B 11.82% | 1.148B 6.10% |
| EBIT Q2Q % growth | 1.069B -47.88% | 1.062B -43.62% | 1.201B -39.97% | 1.149B -56.60% | 1.171B 9.54% | 1.121B 5.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.96 15.62% | 2.95 | 0.01 | 0.43% |
| Q1 2025 Q2Q % growth | 2.80 12.00% | 2.84 | -0.04 | -1.28% |
| Q4 2024 Q2Q % growth | 2.52 6.33% | 2.47 | 0.05 | 2.05% |
| Q3 2024 Q2Q % growth | 2.68 19.11% | 2.68 | 0.00 | -0.04% |
| Q2 2024 Q2Q % growth | 2.56 11.30% | 2.56 | 0.00 | 0.05% |
| Q1 2024 Q2Q % growth | 2.50 3.31% | 2.48 | 0.02 | 0.99% |
| Q4 2023 Q2Q % growth | 2.37 23.44% | 2.31 | 0.06 | 2.81% |
| Q3 2023 Q2Q % growth | 2.25 13.64% | 2.24 | 0.01 | 0.25% |
| Q2 2023 Q2Q % growth | 2.30 16.75% | 2.22 | 0.08 | 3.47% |
| Q1 2023 Q2Q % growth | 2.42 14.69% | 2.40 | 0.02 | 0.87% |
| Q4 2022 Q2Q % growth | 1.92 15.66% | 1.90 | 0.02 | 1.05% |
| Q3 2022 Q2Q % growth | 1.98 23.75% | 1.96 | 0.02 | 1.23% |
| Q2 2022 Q2Q % growth | 1.97 20.12% | 1.95 | 0.02 | 0.82% |
| Q1 2022 Q2Q % growth | 2.11 17.88% | 2.02 | 0.09 | 4.40% |
| Q4 2021 Q2Q % growth | 1.66 19.42% | 1.66 | 0.00 | 0.19% |
| Q3 2021 Q2Q % growth | 1.60 15.94% | 1.58 | 0.02 | 1.56% |
| Q2 2021 Q2Q % growth | 1.64 0.61% | 1.62 | 0.02 | 1.08% |
| Q1 2021 Q2Q % growth | 1.79 -23.18% | 1.76 | 0.03 | 1.52% |
| Q4 2020 Q2Q % growth | 1.39 -8.55% | 1.38 | 0.01 | 0.64% |
| Q3 2020 Q2Q % growth | 1.38 -27.37% | 1.42 | -0.04 | -3.13% |
| Q2 2020 Q2Q % growth | 1.63 -7.39% | 1.64 | -0.01 | -0.31% |
| Q1 2020 Q2Q % growth | 2.33 43.83% | 2.25 | 0.08 | 3.33% |
| Q4 2019 Q2Q % growth | 1.52 | 1.56 | -0.04 | -2.48% |
| Q3 2019 Q2Q % growth | 1.90 | 1.78 | 0.12 | 6.68% |
| Q2 2019 Q2Q % growth | 1.76 | 1.78 | -0.02 | -1.27% |
| Q1 2019 Q2Q % growth | 1.62 | 1.62 | 0.00 | 0.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.692B 10.41% | 1.711B | -19M | -1.11% |
| Q1 2025 Q2Q % growth | 1.642B 10.38% | 1.671B | -28.7M | -1.72% |
| Q4 2024 Q2Q % growth | 1.525B 5.98% | 1.534B | -8.7M | -0.57% |
| Q3 2024 Q2Q % growth | 1.584B 18.43% | 1.595B | -10.6M | -0.66% |
| Q2 2024 Q2Q % growth | 1.533B 12.67% | 1.549B | -16.5M | -1.07% |
| Q1 2024 Q2Q % growth | 1.488B 3.21% | 1.496B | -8.1M | -0.54% |
| Q4 2023 Q2Q % growth | 1.439B -39.01% | 1.443B | -3.7M | -0.26% |
| Q3 2023 Q2Q % growth | 1.338B -30.10% | 1.355B | -17.2M | -1.27% |
| Q2 2023 Q2Q % growth | 1.36B -10.75% | 1.354B | 6.2M | 0.46% |
| Q1 2023 Q2Q % growth | 1.442B 1.54% | 1.406B | 35.6M | 2.53% |
| Q4 2022 Q2Q % growth | 2.36B 94.22% | 1.224B | 1.136B | 92.81% |
| Q3 2022 Q2Q % growth | 1.914B 52.42% | 1.233B | 681M | 55.23% |
| Q2 2022 Q2Q % growth | 1.524B 22.75% | 1.258B | 266.1M | 21.15% |
| Q1 2022 Q2Q % growth | 1.42B 10.55% | 1.328B | 91.7M | 6.91% |
| Q4 2021 Q2Q % growth | 1.215B 7.57% | 1.182B | 33.1M | 2.80% |
| Q3 2021 Q2Q % growth | 1.256B 13.71% | 1.163B | 92.7M | 7.97% |
| Q2 2021 Q2Q % growth | 1.242B 2.24% | 1.184B | 57.6M | 4.86% |
| Q1 2021 Q2Q % growth | 1.284B -20.63% | 1.27B | 14.2M | 1.12% |
| Q4 2020 Q2Q % growth | 1.13B -12.16% | 1.11B | 19.6M | 1.77% |
| Q3 2020 Q2Q % growth | 1.104B -13.54% | 1.105B | -700K | -0.06% |
| Q2 2020 Q2Q % growth | 1.214B -4.58% | 1.207B | 7.4M | 0.61% |
| Q1 2020 Q2Q % growth | 1.618B 37.17% | 1.509B | 109M | 7.22% |
| Q4 2019 Q2Q % growth | 1.286B | 1.172B | 114M | 9.73% |
| Q3 2019 Q2Q % growth | 1.277B | 1.282B | -4.7M | -0.37% |
| Q2 2019 Q2Q % growth | 1.273B | 1.293B | -20.3M | -1.57% |
| Q1 2019 Q2Q % growth | 1.18B | 1.202B | -22.4M | -1.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.16% | -0.33% | -0.29% | 1.68% |
| Revenue | -4.02% | -2.78% | -1.69% | -0.65% |